ZAI LAB LIMITED
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-175.5M | $-257.1M | $-334.6M | $-443.3M | $-704.5M | $-268.9M | $-195.1M | $-139.1M |
| Depreciation & Amortization | $15.0M | $11.9M | $9.0M | $8.2M | $6.5M | $4.6M | $3.8M | $1.7M |
| Depreciation | $9.1M | $8.6M | $8.4M | $7.7M | $6.0M | $4.3M | $3.4M | $4.3M |
| Amortization | $5.9M | $3.2M | $700.0K | $500.0K | $500.0K | $300.0K | $305.0K | $15.0K |
| Stock-Based Compensation | $65.6M | $70.7M | $79.6M | $61.3M | $40.7M | $24.8M | $20.3M | $12.2M |
| Net Cash from Operating Activities | $-150.8M | $-214.9M | $-198.2M | $-367.6M | $-549.2M | $-216.1M | $-191.0M | $-97.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $8.1M | $5.7M | $7.2M | $24.6M | $18.3M | $10.1M | $6.0M | $10.0M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $307.9M | $-375.2M | $-10.8M | $420.0M | $250.0M | $-554.8M | $-14.9M | $-212.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $72.4M | $349.9M | $-6.4M | $-1.7M | $820.2M | $1.13B | $219.3M | $144.1M |
| Net Change in Cash | $229.9M | $-240.5M | $-218.0M | $44.4M | $522.0M | $366.4M | $13.5M | $-166.7M |
| Free Cash Flow | $-158.9M | $-220.5M | $-205.4M | $-392.2M | $-567.5M | $-226.2M | $-197.0M | $-107.6M |